Chems

[ad_1] LG Chem researchers conduct experiments in the company’s laboratories. [LG CHEM] LG Chem has entered into a $95.5 million technology transfer agreement with Nanjing-based Innovent Biologics for gout treatment candidate Tigulixostat. Under the deal, HKEX-listed Innovent Biologics will have exclusive rights to develop and market the gout treatment in China, while LG will retain … Read moreLG Chem’s ink has partnered with Innovent Biologics for the treatment of gout

| Jobs Vox